Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic emulsion) 0.1%, a prescription treatment for vernal keratoconjunctivitis (VKC), a serious allergic eye condition that primarily affects children. The eye care company said the move reflects its continued…
SanDisk Corporation (NASDAQ:SNDK) stock climbed nearly 6% on Thursday as investors continued to favor high-growth technology stocks amid a broader risk-on market environment. SanDisk continues to benefit from the AI infrastructure buildout, as rising demand for high-performance NAND storage and…
The Trade Desk Inc (NASDAQ:TTD) shares are trading lower on Thursday, hitting new 52-week lows as traders weigh a growth-rotation rebound narrative against a longer-term chart that's still in repair mode. Trade Desk shares are approaching critical lows. Why is…
Oracle (NYSE:ORCL) reported record fourth quarter revenue and beat analyst estimates Wednesday night, but the stock fell on weaker-than-expected guidance. The stock's drop has made co-founder Larry Ellison worth significantly less and falling down the billionaires list. Larry Ellison's Wealth…
Humacyte Inc. (NASDAQ:HUMA) stock plunged Thursday despite reporting positive interim Phase 3 data for its acellular tissue-engineered vessel (ATEV), as investors focused on a heavily dilutive stock offering announced alongside the clinical update. On Wednesday, Humacyte released interim Phase 3…
